This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is true concerning flow-dependent incentive spirometry devices? a. The ... (Read 95 times)

anjilletteb

  • Hero Member
  • *****
  • Posts: 569
Which of the following is true concerning flow-dependent incentive spirometry devices?
 
  a. The volume capacity for a child should be approximately 3 L.
  b. The patient must perform a sustained maximum inspiration.
  c. They are available as multiuse electrically powered devices.
  d. Positive pressure within the device causes the flexible plastic bellows to rise.

Question 2

A patient has undergone surgery and is receiving continuous supplemental oxygen via a 30 air-entrainment mask.
 
  He or she becomes pale and short of breath during incentive spirometry. Pulse oximetry reveals a significant drop in oxygen saturation during incentive spirometry. The respiratory therapist should do which of the following for subsequent incentive spirometry therapy?
  a. Switch to a different type of incentive spirometer.
  b. Request that incentive spirometry be dis-continued.
  c. Cut a hole in the mask for the incentive spirometer's mouthpiece.
  d. Use a 3 L/min nasal cannula during incen-tive spirometry.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wshriver

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

ANS: B
The performance of a sustained maximum inspiration is necessary to perform incentive spirometry with a flow-dependent incentive spirometer (or any incentive spirometry device).

Answer to Question 2

ANS: D
The drop in oxygen saturation during incentive spirometry is due to the interruption of oxygen therapy. For this patient it is necessary to maintain oxygen therapy during incentive spirometry. Because the use of a mask is difficult during incentive spirometry, a nasal cannula with a flow rate of 3 L/min will approximate the air-entrainment mask's 30 supplemental oxygen.





 

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library